Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Clinical trial NCT06233071 · UNKNOWN

Trial details

NCT number: NCT06233071
Sponsor: Bio-innova Co., Ltd
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-02-13
Primary completion: 2024-04-04
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.